Alan Kirk, ERS 2021: The TRANSFORM Study – A 24-month Follow-up

We were delighted to catch up with Mr Alan Kirk (Golden Jubilee National Hospital, West Dunbartonshire, Scotland, UK) to discuss the 24-month follow-up to the TRANSFORM study, investigating endobronchial valve treatment for patients with severe heterogeneous emphysema. The abstract ‘Durability of Zephyr Valve treatment: 24-month follow-up in the TRANSFORM Study.‘ (Presentation ID: 1201) was presented at […]

Andrew Menzies-Gow, ERS 2021: Benralizumab Following Oral Corticosteroid Reduction in Severe Asthma

TouchRESPIRATORY got the opportunity to catch up with Professor Andrew Menzies-Gow (Royal Brompton Hospital and Imperial College London, London, UK) to discuss oral corticosteroid (OCS) dependency in severe asthma and the use of benralizumab following OCS reduction. The abstract ‘Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study.’ (ID:1460) was presented at […]

Peter Dicpinigaitis, ERS 2021: Unmet Needs and Advances in Chronic Cough

TouchRESPIRATORY got the opportunity to catch up with Professor Peter Dicpinigaitis (Albert Einstein College of Medicine and Montefiore Cough Center, NY, USA) to learn more about the unmet needs in chronic cough and recent clinical advances. Questions What are the unmet needs in the treatment of patients with refractory or unexplained chronic cough (RCC or […]

Vincent Cottin, ERS 2021: GLPG1205 for Idiopathic Pulmonary Fibrosis

Professor Vincent Cottin (National Reference Centre for Rare Pulmonary Diseases, Lyon, France) spoke with touchRESPIRATORY around the Phase 2 PINTA study, investigating GLPG1205 for idiopathic pulmonary fibrosis. The abstract ‘Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA).’ (Presentation ID 2904) was presented at ERS International Congress 2021, 5-8 September 2021. […]

Dupilumab—A Potential New Biologic for Chronic Rhinosinusitis with Nasal Polyps

US Respiratory & Pulmonary Diseases. 2020;5(1):15-7 DOI: https://doi.org/10.17925/USPRD.2020.5.1.15

Chronic rhinosinusitis (CRS) is a clinical syndrome defined by symptomatic inflammation of the paranasal sinuses and nasal cavity for at least 12 weeks in duration. Historically, CRS has been classified into 2 subgroups, CRS with nasal polyps (CRSwNP) and CRS without nasal polyps. Those with CRSwNP have a more significant burden of disease and poor […]

Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung Disease

US Respiratory and Pulmonary Diseases. 2020;5(1):28-32 DOI: https://doi.org/10.17925/USPRD.2020.5.1.28

Systemic sclerosis (SSc) is an autoimmune disorder characterized by inflammation and fibrosis of the skin and other organs. It has a range of clinical manifestations, and the typical internal organs involved include the lungs, kidneys, heart, and gastrointestinal tract. Though it is an uncommon condition, the mortality rate of this disease is higher than any […]

Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection

touchREVIEWS in Respiratory & Pulmonary Medicine. 2021;6(1):Online ahead of publication

Respiratory syncytial virus (RSV) is a ubiquitous virus that causes annual epidemics of infection in young children in all parts of the world. In temperate regions, epidemics are seasonal, and predictable during the winter months. Approximately half of all infants develop their first RSV infection prior to their first birthday. By 24 months of age, […]

Sleep Disorders in Neuromuscular Diseases: Adaption in Care Provision During the COVID-19 Pandemic

touchREVIEWS in Respiratory & Pulmonary Medicine. 2021;6(1):Online ahead of journal publication

Sleep disturbances are exceedingly common and potentially morbid in patients with neuromuscular diseases (NMD).1 A constellation of physiologic changes occur in patients with NMDs which, in concert with normal physiologic changes during sleep, lead to decreased nocturnal ventilation that often precedes daytime hypoventilation. The standard manner in which we diagnose and treat sleep disorders in this […]